Nano HoldingsNano Holdings, Inc.4571東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP
Nano Holdings brought in ¥135.5M in revenue.
It lost about ¥638 for every ¥100 of sales at the operating level.
Revenue changed -33.0% from the prior year.
FY ending Mar 2023 → FY ending Mar 2024
FY ending Mar 2023 → FY ending Mar 2024
For every ¥100 Nano Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第30期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第29期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第28期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第27期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
有価証券報告書-第26期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第25期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 43
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.